Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Recombinant Human Interferon α1b Market Growth (Status and Outlook) 2022-2028

  • LP 4810925
  • 61 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Recombinant Human Interferon α1b will have significant change from previous year. According to our (LP Information) latest study, the global Recombinant Human Interferon α1b market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Recombinant Human Interferon α1b market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Recombinant Human Interferon α1b market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Recombinant Human Interferon α1b market, reaching US$ million by the year 2028. As for the Europe Recombinant Human Interferon α1b landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Recombinant Human Interferon α1b players cover Beijing Tri-Prime Gene Pharmaceutical Co., Ltd., Shenzhen Kexing Biological Technology Co., Ltd., , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Interferon α1b market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Injection

Spray

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Chronic Hepatitis B

Hairy Cell Leukemia

Hepatitis C

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Beijing Tri-Prime Gene Pharmaceutical Co., Ltd.

Shenzhen Kexing Biological Technology Co., Ltd.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant Human Interferon α1b Market Size 2017-2028

2.1.2 Recombinant Human Interferon α1b Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Recombinant Human Interferon α1b Segment by Type

2.2.1 Injection

2.2.2 Spray

2.3 Recombinant Human Interferon α1b Market Size by Type

2.3.1 Recombinant Human Interferon α1b Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Recombinant Human Interferon α1b Market Size Market Share by Type (2017-2022)

2.4 Recombinant Human Interferon α1b Segment by Application

2.4.1 Chronic Hepatitis B

2.4.2 Hairy Cell Leukemia

2.4.3 Hepatitis C

2.5 Recombinant Human Interferon α1b Market Size by Application

2.5.1 Recombinant Human Interferon α1b Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Recombinant Human Interferon α1b Market Size Market Share by Application (2017-2022)

3 Recombinant Human Interferon α1b Market Size by Player

3.1 Recombinant Human Interferon α1b Market Size Market Share by Players

3.1.1 Global Recombinant Human Interferon α1b Revenue by Players (2020-2022)

3.1.2 Global Recombinant Human Interferon α1b Revenue Market Share by Players (2020-2022)

3.2 Global Recombinant Human Interferon α1b Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Recombinant Human Interferon α1b by Regions

4.1 Recombinant Human Interferon α1b Market Size by Regions (2017-2022)

4.2 Americas Recombinant Human Interferon α1b Market Size Growth (2017-2022)

4.3 APAC Recombinant Human Interferon α1b Market Size Growth (2017-2022)

4.4 Europe Recombinant Human Interferon α1b Market Size Growth (2017-2022)

4.5 Middle East & Africa Recombinant Human Interferon α1b Market Size Growth (2017-2022)

5 Americas

5.1 Americas Recombinant Human Interferon α1b Market Size by Country (2017-2022)

5.2 Americas Recombinant Human Interferon α1b Market Size by Type (2017-2022)

5.3 Americas Recombinant Human Interferon α1b Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant Human Interferon α1b Market Size by Region (2017-2022)

6.2 APAC Recombinant Human Interferon α1b Market Size by Type (2017-2022)

6.3 APAC Recombinant Human Interferon α1b Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Recombinant Human Interferon α1b by Country (2017-2022)

7.2 Europe Recombinant Human Interferon α1b Market Size by Type (2017-2022)

7.3 Europe Recombinant Human Interferon α1b Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant Human Interferon α1b by Region (2017-2022)

8.2 Middle East & Africa Recombinant Human Interferon α1b Market Size by Type (2017-2022)

8.3 Middle East & Africa Recombinant Human Interferon α1b Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Recombinant Human Interferon α1b Market Forecast

10.1 Global Recombinant Human Interferon α1b Forecast by Regions (2023-2028)

10.1.1 Global Recombinant Human Interferon α1b Forecast by Regions (2023-2028)

10.1.2 Americas Recombinant Human Interferon α1b Forecast

10.1.3 APAC Recombinant Human Interferon α1b Forecast

10.1.4 Europe Recombinant Human Interferon α1b Forecast

10.1.5 Middle East & Africa Recombinant Human Interferon α1b Forecast

10.2 Americas Recombinant Human Interferon α1b Forecast by Country (2023-2028)

10.2.1 United States Recombinant Human Interferon α1b Market Forecast

10.2.2 Canada Recombinant Human Interferon α1b Market Forecast

10.2.3 Mexico Recombinant Human Interferon α1b Market Forecast

10.2.4 Brazil Recombinant Human Interferon α1b Market Forecast

10.3 APAC Recombinant Human Interferon α1b Forecast by Region (2023-2028)

10.3.1 China Recombinant Human Interferon α1b Market Forecast

10.3.2 Japan Recombinant Human Interferon α1b Market Forecast

10.3.3 Korea Recombinant Human Interferon α1b Market Forecast

10.3.4 Southeast Asia Recombinant Human Interferon α1b Market Forecast

10.3.5 India Recombinant Human Interferon α1b Market Forecast

10.3.6 Australia Recombinant Human Interferon α1b Market Forecast

10.4 Europe Recombinant Human Interferon α1b Forecast by Country (2023-2028)

10.4.1 Germany Recombinant Human Interferon α1b Market Forecast

10.4.2 France Recombinant Human Interferon α1b Market Forecast

10.4.3 UK Recombinant Human Interferon α1b Market Forecast

10.4.4 Italy Recombinant Human Interferon α1b Market Forecast

10.4.5 Russia Recombinant Human Interferon α1b Market Forecast

10.5 Middle East & Africa Recombinant Human Interferon α1b Forecast by Region (2023-2028)

10.5.1 Egypt Recombinant Human Interferon α1b Market Forecast

10.5.2 South Africa Recombinant Human Interferon α1b Market Forecast

10.5.3 Israel Recombinant Human Interferon α1b Market Forecast

10.5.4 Turkey Recombinant Human Interferon α1b Market Forecast

10.5.5 GCC Countries Recombinant Human Interferon α1b Market Forecast

10.6 Global Recombinant Human Interferon α1b Forecast by Type (2023-2028)

10.7 Global Recombinant Human Interferon α1b Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Beijing Tri-Prime Gene Pharmaceutical Co., Ltd.

11.1.1 Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Company Information

11.1.2 Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Recombinant Human Interferon α1b Product Offered

11.1.3 Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Recombinant Human Interferon α1b Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Main Business Overview

11.1.5 Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Latest Developments

11.2 Shenzhen Kexing Biological Technology Co., Ltd.

11.2.1 Shenzhen Kexing Biological Technology Co., Ltd. Company Information

11.2.2 Shenzhen Kexing Biological Technology Co., Ltd. Recombinant Human Interferon α1b Product Offered

11.2.3 Shenzhen Kexing Biological Technology Co., Ltd. Recombinant Human Interferon α1b Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Shenzhen Kexing Biological Technology Co., Ltd. Main Business Overview

11.2.5 Shenzhen Kexing Biological Technology Co., Ltd. Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Recombinant Human Interferon α1b Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Injection

Table 3. Major Players of Spray

Table 4. Recombinant Human Interferon α1b Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Recombinant Human Interferon α1b Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Recombinant Human Interferon α1b Market Size Market Share by Type (2017-2022)

Table 7. Recombinant Human Interferon α1b Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Recombinant Human Interferon α1b Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Recombinant Human Interferon α1b Market Size Market Share by Application (2017-2022)

Table 10. Global Recombinant Human Interferon α1b Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Recombinant Human Interferon α1b Revenue Market Share by Player (2020-2022)

Table 12. Recombinant Human Interferon α1b Key Players Head office and Products Offered

Table 13. Recombinant Human Interferon α1b Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Recombinant Human Interferon α1b Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Recombinant Human Interferon α1b Market Size Market Share by Regions (2017-2022)

Table 18. Americas Recombinant Human Interferon α1b Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Recombinant Human Interferon α1b Market Size Market Share by Country (2017-2022)

Table 20. Americas Recombinant Human Interferon α1b Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Recombinant Human Interferon α1b Market Size Market Share by Type (2017-2022)

Table 22. Americas Recombinant Human Interferon α1b Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Recombinant Human Interferon α1b Market Size Market Share by Application (2017-2022)

Table 24. APAC Recombinant Human Interferon α1b Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Recombinant Human Interferon α1b Market Size Market Share by Region (2017-2022)

Table 26. APAC Recombinant Human Interferon α1b Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Recombinant Human Interferon α1b Market Size Market Share by Type (2017-2022)

Table 28. APAC Recombinant Human Interferon α1b Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Recombinant Human Interferon α1b Market Size Market Share by Application (2017-2022)

Table 30. Europe Recombinant Human Interferon α1b Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Recombinant Human Interferon α1b Market Size Market Share by Country (2017-2022)

Table 32. Europe Recombinant Human Interferon α1b Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Recombinant Human Interferon α1b Market Size Market Share by Type (2017-2022)

Table 34. Europe Recombinant Human Interferon α1b Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Recombinant Human Interferon α1b Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Recombinant Human Interferon α1b Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Recombinant Human Interferon α1b Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Recombinant Human Interferon α1b Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Recombinant Human Interferon α1b Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Recombinant Human Interferon α1b Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Recombinant Human Interferon α1b Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Recombinant Human Interferon α1b

Table 43. Key Market Challenges & Risks of Recombinant Human Interferon α1b

Table 44. Key Industry Trends of Recombinant Human Interferon α1b

Table 45. Global Recombinant Human Interferon α1b Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Recombinant Human Interferon α1b Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Recombinant Human Interferon α1b Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Recombinant Human Interferon α1b Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Recombinant Human Interferon α1b Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Recombinant Human Interferon α1b Market Size Market Share Forecast by Application (2023-2028)

Table 51. Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Details, Company Type, Recombinant Human Interferon α1b Area Served and Its Competitors

Table 52. Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Recombinant Human Interferon α1b Product Offered

Table 53. Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Recombinant Human Interferon α1b Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Main Business

Table 55. Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Latest Developments

Table 56. Shenzhen Kexing Biological Technology Co., Ltd. Details, Company Type, Recombinant Human Interferon α1b Area Served and Its Competitors

Table 57. Shenzhen Kexing Biological Technology Co., Ltd. Recombinant Human Interferon α1b Product Offered

Table 58. Shenzhen Kexing Biological Technology Co., Ltd. Main Business

Table 59. Shenzhen Kexing Biological Technology Co., Ltd. Recombinant Human Interferon α1b Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Shenzhen Kexing Biological Technology Co., Ltd. Latest Developments

List of Figures

Figure 1. Recombinant Human Interferon α1b Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Recombinant Human Interferon α1b Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Recombinant Human Interferon α1b Market Size Market Share by Type in 2021

Figure 7. Recombinant Human Interferon α1b in Chronic Hepatitis B

Figure 8. Global Recombinant Human Interferon α1b Market: Chronic Hepatitis B (2017-2022) & ($ Millions)

Figure 9. Recombinant Human Interferon α1b in Hairy Cell Leukemia

Figure 10. Global Recombinant Human Interferon α1b Market: Hairy Cell Leukemia (2017-2022) & ($ Millions)

Figure 11. Recombinant Human Interferon α1b in Hepatitis C

Figure 12. Global Recombinant Human Interferon α1b Market: Hepatitis C (2017-2022) & ($ Millions)

Figure 13. Global Recombinant Human Interferon α1b Market Size Market Share by Application in 2021

Figure 14. Global Recombinant Human Interferon α1b Revenue Market Share by Player in 2021

Figure 15. Global Recombinant Human Interferon α1b Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Recombinant Human Interferon α1b Market Size 2017-2022 ($ Millions)

Figure 17. APAC Recombinant Human Interferon α1b Market Size 2017-2022 ($ Millions)

Figure 18. Europe Recombinant Human Interferon α1b Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Recombinant Human Interferon α1b Market Size 2017-2022 ($ Millions)

Figure 20. Americas Recombinant Human Interferon α1b Value Market Share by Country in 2021

Figure 21. Americas Recombinant Human Interferon α1b Consumption Market Share by Type in 2021

Figure 22. Americas Recombinant Human Interferon α1b Market Size Market Share by Application in 2021

Figure 23. United States Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Recombinant Human Interferon α1b Market Size Market Share by Region in 2021

Figure 28. APAC Recombinant Human Interferon α1b Market Size Market Share by Application in 2021

Figure 29. China Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Recombinant Human Interferon α1b Market Size Market Share by Country in 2021

Figure 36. Europe Recombinant Human Interferon α1b Market Size Market Share by Type in 2021

Figure 37. Europe Recombinant Human Interferon α1b Market Size Market Share by Application in 2021

Figure 38. Germany Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Recombinant Human Interferon α1b Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Recombinant Human Interferon α1b Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Recombinant Human Interferon α1b Market Size Market Share by Application in 2021

Figure 46. Egypt Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Recombinant Human Interferon α1b Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 52. APAC Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 53. Europe Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 55. United States Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 56. Canada Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 59. China Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 60. Japan Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 61. Korea Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 63. India Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 64. Australia Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 65. Germany Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 66. France Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 67. UK Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 68. Italy Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 69. Russia Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 70. Spain Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 73. Israel Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Recombinant Human Interferon α1b Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390